TB-500 (Thymosin Beta-4): The Complete Guide (2026)

What Is TB-500?

TB-500 is a synthetic peptide that corresponds to the active region of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid protein found in virtually all human and animal cells. Thymosin Beta-4 was first identified in the thymus gland and plays a central role in cellular processes related to wound healing, tissue repair, and protection from injury.

TB-500 specifically represents the active fragment of Thymosin Beta-4 responsible for its actin-binding and cell migration properties. By isolating this region, researchers can study the healing-related effects of the full protein in a more targeted manner. TB-500 has been investigated in preclinical research since the early 2000s, with studies examining its potential applications in tissue repair and recovery.

Like other research peptides, TB-500 is not approved by the FDA for any medical use. It is classified as a research compound and is primarily available for investigational purposes. Despite this, it remains one of the most widely discussed peptides in the research and recovery communities, frequently compared to BPC-157 for its complementary healing mechanisms.

How Does TB-500 Work?

TB-500's mechanisms of action have been studied across multiple preclinical models. The peptide appears to exert its effects through several key biological pathways:

Actin Upregulation

The primary mechanism attributed to TB-500 is its ability to upregulate the protein actin, a critical component of cell structure and movement. Actin is essential for cell migration, which is a foundational step in wound healing and tissue repair. By increasing actin availability, TB-500 may help cells move more efficiently to sites of damage.

Cell Migration & Proliferation

Research in animal models suggests that TB-500 promotes the migration of endothelial cells and keratinocytes to wound sites. This enhanced cell migration appears to accelerate the formation of new tissue, which is a critical phase of the healing process. Studies also indicate it may promote cell differentiation in damaged tissues.

Angiogenesis

Published studies suggest TB-500 may promote angiogenesis — the growth of new blood vessels from existing vasculature. Increased blood supply to injured areas delivers more oxygen, nutrients, and immune cells, all of which are essential for effective tissue repair. This property has been observed in multiple animal models of wound healing.

Anti-Inflammatory Activity

Preclinical research indicates TB-500 may reduce inflammation at injury sites by modulating the release of inflammatory cytokines. This anti-inflammatory activity appears to work alongside its tissue-repair properties, potentially creating a more favorable environment for healing while reducing pain and swelling associated with injury.

TB-500 vs BPC-157

TB-500 and BPC-157 are the two most commonly discussed healing peptides in the research community. While both are investigated for their tissue-repair potential, they operate through distinct mechanisms and may offer complementary effects.

Different Origins

BPC-157 is derived from a protein found in human gastric juice, while TB-500 is a synthetic fragment of Thymosin Beta-4, a protein found throughout the body. Their different origins contribute to their distinct mechanisms of action and the types of tissues they appear to influence most strongly in preclinical research.

Different Mechanisms

BPC-157 appears to work primarily through the nitric oxide pathway, growth factor modulation, and the gut-brain axis. TB-500, on the other hand, acts primarily through actin upregulation and enhanced cell migration. BPC-157 research has focused heavily on tendon, ligament, and gut healing, while TB-500 research has examined broader systemic tissue repair, including muscle and cardiac tissue.

Complementary Stacking

Due to their differing mechanisms, some researchers discuss using BPC-157 and TB-500 together. The theory is that BPC-157's localized healing effects (particularly when injected near the site of injury) may complement TB-500's more systemic, whole-body approach. However, this combination has not been evaluated in controlled human clinical trials, and the safety profile of the stack is not established. Researchers should exercise caution and consult a healthcare professional before considering any combination protocol.

Key Differences at a Glance

• Origin: BPC-157 (gastric juice) vs TB-500 (Thymosin Beta-4 fragment)
• Primary mechanism: BPC-157 (nitric oxide, growth factors) vs TB-500 (actin regulation, cell migration)
• Administration: BPC-157 may be effective orally; TB-500 is typically administered via injection
• Scope: BPC-157 is often discussed for localized healing; TB-500 is discussed for systemic effects
• Dosing frequency: BPC-157 is commonly dosed daily; TB-500 is often dosed 1–2 times per week

For a detailed breakdown of BPC-157, read our BPC-157 Complete Guide.

Potential Benefits

The following potential benefits are based on published preclinical research, primarily in animal models. Human clinical trials are limited, and these should not be interpreted as guaranteed outcomes.

Injury Recovery & Wound Healing

TB-500's most widely studied application is in wound healing and injury recovery. Research in animal models suggests it may accelerate the healing of skin wounds, surgical incisions, and soft tissue injuries by promoting cell migration and new blood vessel formation. Some equine studies have examined its effects on tendon and ligament injuries in horses.

Muscle Repair

Preclinical studies have investigated TB-500's effects on damaged muscle tissue. Research in animal models indicates it may promote the regeneration of muscle fibers and reduce scar tissue formation following injury. These findings have generated significant interest among researchers studying recovery from muscle strains and tears. Some researchers pair TB-500 with growth hormone peptides like Ipamorelin to further support recovery.

Flexibility & Reduced Stiffness

Some researchers and community reports suggest TB-500 may improve flexibility and reduce tissue stiffness, potentially by promoting tissue remodeling and reducing adhesions. This effect is thought to be related to its actin-regulating properties, though controlled studies on this specific outcome are limited.

Hair Growth Research

Emerging preclinical research has explored Thymosin Beta-4's potential role in hair follicle biology. Animal studies suggest it may promote the migration of hair follicle stem cells to the skin surface, potentially supporting new hair growth. This area of research is still in its early stages, and results in humans have not been established through clinical trials. For skin and hair-related applications, researchers may also be interested in GHK-Cu, a copper peptide with published research on hair follicle support.

Cardiac Repair Research

Some of the most intriguing preclinical research on Thymosin Beta-4 involves its potential effects on cardiac tissue. Animal studies have examined whether it may support the repair of heart muscle following injury, potentially by activating cardiac progenitor cells and promoting new blood vessel growth in damaged heart tissue. This remains an active area of investigation in academic research settings.

Dosage Guidelines

Disclaimer: The following information is based on protocols described in published research literature and community reports. This is not medical advice. Always consult a healthcare professional before using any research compound.

Loading Phase

Research protocols and community reports commonly describe a loading phase for TB-500 to build initial tissue saturation. The most frequently cited loading protocol involves 4–8mg per week, typically split into 2 injections per week (e.g., 2–4mg twice weekly). This loading phase is generally described as lasting 4–6 weeks.

Maintenance Phase

Following the loading phase, many research protocols describe transitioning to a lower maintenance dose. The commonly discussed maintenance dosage is 2–4mg administered every two weeks. Some protocols describe monthly administration at similar doses during the maintenance period. The optimal maintenance schedule has not been established through clinical trials.

Administration Route

TB-500 is most commonly discussed as being administered via subcutaneous injection. Unlike BPC-157, TB-500 is not typically discussed as having oral bioavailability. Key points about administration:

• Subcutaneous injection: The most commonly described method. TB-500 is considered to have systemic effects, so injection site proximity to the injury is generally considered less important than with some other peptides.
• Intramuscular injection: Some protocols describe intramuscular administration, though subcutaneous is more commonly discussed.

Cycle Length

A typical research cycle described in community protocols spans approximately 8–12 weeks total (4–6 weeks loading plus 4–6 weeks maintenance). Some researchers describe running longer cycles for chronic conditions, while others cycle on and off. Optimal cycle length has not been determined through controlled clinical trials.

How to Reconstitute TB-500

TB-500 typically ships as a lyophilized (freeze-dried) powder in a sealed vial. Reconstitution is the process of adding a sterile solvent to prepare it for use. Here is the standard protocol:

What You Need

• TB-500 lyophilized vial (commonly 5mg)
• Bacteriostatic water (BAC water)
• Insulin syringes (1ml / 100 unit)
• Alcohol swabs

Step-by-Step Reconstitution

1. Clean the vial tops: Wipe the rubber stoppers of both the TB-500 vial and the bacteriostatic water vial with alcohol swabs.
2. Draw the BAC water: Using an insulin syringe, draw your desired amount of bacteriostatic water. For a 5mg vial, 1ml of BAC water is a common choice, which yields 500mcg per 0.1ml (10 units on the syringe).
3. Add water slowly: Insert the needle into the TB-500 vial and let the water drip down the side of the glass. Do not spray directly onto the powder, as this can damage the peptide.
4. Gently swirl: Once the water is added, gently swirl the vial until the powder is fully dissolved. Do not shake vigorously.
5. Store properly: Reconstituted TB-500 should be stored in the refrigerator (2–8°C). Most sources recommend using it within 3–4 weeks after reconstitution.

Dosage Math Example

If you reconstitute a 5mg vial with 1ml of BAC water:

• 5mg / 1ml = 5mg per ml = 5,000mcg per ml
• 2mg dose = 0.4ml = 40 units on an insulin syringe
• 2.5mg dose = 0.5ml = 50 units on an insulin syringe
• One 5mg vial at 2.5mg twice/week = 1 week of loading-phase use

Side Effects & Safety

TB-500 has shown a generally favorable safety profile in the preclinical studies conducted to date. However, it is important to emphasize that comprehensive human safety data from large-scale clinical trials is currently lacking.

What Research Shows

In animal studies, Thymosin Beta-4 and its synthetic fragment TB-500 have generally been well-tolerated. Some research has examined its safety in equine models, where it has been used more extensively than in human studies. Published research has not identified significant toxic effects at commonly studied dosages, though long-term data in humans remains unavailable.

Commonly Reported Side Effects

Based on community reports (not clinical data), the most commonly mentioned side effects include:

• Head rush or temporary lightheadedness shortly after injection
• Lethargy or fatigue, particularly during the loading phase
• Redness, swelling, or irritation at the injection site
• Mild flu-like symptoms in some individuals during early use
• Temporary nausea

Important Safety Considerations

• Not FDA-approved: TB-500 is not approved for human use by the FDA or any other regulatory body. It is sold as a research chemical.
• Limited human data: Most safety data comes from animal studies. The long-term effects in humans are not well established.
• Cancer considerations: Because TB-500 promotes cell migration and angiogenesis, some researchers have raised theoretical concerns about its use in individuals with a history of cancer. No direct link has been established, but caution is warranted. Individuals with active cancer or a history of cancer should consult an oncologist.
• Potential interactions: The effects of TB-500 in combination with other compounds or medications have not been thoroughly studied in clinical settings.
• Quality control: As a research peptide, product quality can vary significantly between vendors. Third-party testing is essential.

Where to Buy TB-500

Sourcing high-quality TB-500 is critical. The research peptide market includes vendors of varying quality, and purchasing from an unreliable source can mean receiving underdosed, degraded, or contaminated product. Here are our top recommended vendors for 2026, evaluated on purity, third-party testing, pricing, and customer service.

Disclosure: This page contains affiliate links. If you purchase through our links, we may earn a commission at no extra cost to you. This helps support our independent research and content. We only recommend vendors we have vetted and trust.

Frequently Asked Questions